| 前收市價 | 128.75 |
| 開市 | 127.90 |
| 買盤 | 0.00 x 0 |
| 賣出價 | 0.00 x 0 |
| 今日波幅 | 127.90 - 134.32 |
| 52 週波幅 | 74.70 - 140.32 |
| 成交量 | |
| 平均成交量 | 29,162 |
| 市值 | 577.233B |
| Beta 值 (5 年，每月) | 0.19 |
| 市盈率 (最近 12 個月) | 45.54 |
| 每股盈利 (最近 12 個月) | 2.87 |
| 業績公佈日 | 2024年8月07日 |
| 遠期股息及收益率 | 1.86 (1.44%) |
| 除息日 | 2024年3月22日 |
| 1 年預測目標價 | 無 |
- Reuters
UPDATE 2-Denmark faces Wegovy shortage due to rising demand
Denmark faces a supply shortage for two doses of Novo Nordisk's Wegovy weight-loss drug in the coming months due to rising demand, the Danish Medicines Agency said on Monday. The hugely popular Wegovy is given by weekly injection and belongs to a class of drugs known as GLP-1 agonists originally developed to treat type 2 diabetes. There will be a shortage of Novo Nordisk's Wegovy Flextouch 1 milligram pen from late May to mid-June, the Danish medicines agency said in a statement.
Motley FoolBillionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
These stocks are both experts in their respective fields.
Motley FoolWant Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
These pharmaceutical companies are top-notch dividend growth stocks for the future.
